Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Clinics in Chest Medicine|August 27, 2011
The use of large databases to study pneumonia: what is their value?Timothy Wiemken, Paula Peyrani, Forest W Arnold, et al.
Vaccine|April 6, 2023
Modeling persistence of hSBA titers over time following a primary series and a booster dose of MenB-FHbpBing Cai, Paula Peyrani, Johannes Beeslaar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract InfectionsJulio Ramirez, Paula Peyrani, Timothy Wiemken, et al.
Diagnostic Microbiology and Infectious Disease|November 16, 2017
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus bone and joint infectionsJulie Harting, Francisco Fernandez, Rob Kelley, et al.
The European Respiratory Journal|July 28, 2012
Outcomes in females hospitalised with community-acquired pneumonia are worse than in malesForest W Arnold, Timothy L Wiemken, Paula Peyrani, et al.
Respiratory Medicine|May 11, 2013
Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort StudyForest W Arnold, Timothy L Wiemken, Paula Peyrani, et al.
American Journal of Infection Control|September 3, 2011
Evaluation of the knowledge-sharing social network of hospital-based infection preventionists in KentuckyTimothy L Wiemken, Julio A Ramirez, Philip Polgreen, et al.
Vaccine|January 9, 2023
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old childrenClare L Cutland, Paula Peyrani, Chris Webber, et al.
Chest|October 20, 2009
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumoniaMehdi Mirsaeidi, Paula Peyrani, Stefano Aliberti, et al.
Chest|January 17, 2008
The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort studyJosé Bordón, Paula Peyrani, Guy N Brock, et al.
Pageof 10